Skip to main content
OpenTrials

Clinical trial condition

Fatty Liver

Explore clinical trials studying Fatty Liver. Study availability and eligibility vary by location and protocol.

953 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Fatty Liver trial results

Completed

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

NCT04210245

Conditions
Compensated Cirrhosis, Digestive System Diseases, Fatty Liver, +3 more
Locations
  • NGM Clinical Study Site Glendale, Arizona, United States
  • NGM Clinical Study Site 413 Tucson, Arizona, United States
  • NGM Clinical Study Site 415 Tucson, Arizona, United States
  • NGM Clinical Study Site North Little Rock, Arkansas, United States
View all 49 locations
View Trial Details
Completed

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

NCT04321031

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • Institute for Liver Health dba Arizona Liver Health Chandler, Arizona, United States
  • Comprehensive Interventional Care Centers (CICC) Gilbert, Arizona, United States
  • The Institute for Liver Health Glendale, Arizona, United States
  • The Institute for Liver Health Peoria, Arizona, United States
View all 291 locations
View Trial Details
Completed

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

NCT05415722

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Site 1017: The Institute for Liver Health dba Arizona Liver Health Chandler, Arizona, United States
  • Site 1018: Arizona Liver Health Tucson, Arizona, United States
  • Site 1004 Southern California Research Center Coronado, California, United States
  • Site 1061 Velocity Clinical Research, Gardena Gardena, California, United States
View all 35 locations
View Trial Details
Completed

A Phase 2b Study of Icosabutate in Fatty Liver Disease

NCT04052516

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Central ResearchAssociates Inc. Birmingham, Alabama, United States
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health - Glendale Glendale, Arizona, United States
  • Arizona Liver Health Tucson, Arizona, United States
View all 39 locations
View Trial Details

Related conditions